Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Head & Neck 2Gynecologic 2Tumor-Agnostic 1Thoracic 1Myeloid 1Gastrointestinal 1Breast 1

Conditions

Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Head and Neck Neoplasms 1

Interventions

Surveys and Questionnaires 40Blood Specimen Collection 30Radiotherapy 20Immunohistochemistry 13Gene Expression Profiling 12Radiotherapy, Intensity-Modulated 11Cisplatin 11Surgical Procedures, Operative 10Biopsy 10Drug Therapy 9Cetuximab 9Ultrasonography 8Thyroidectomy 8Observation 8Transurethral Resection of Prostate 7Nivolumab 7Interviews as Topic 7pembrolizumab 6Therapeutics 6Radiation 6Polymerase Chain Reaction 6Immunotherapy 6Biopsy, Fine-Needle 6Positron Emission Tomography Computed Tomography 5Microarray Analysis 5Liquid Biopsy 5Iodine-131 5Docetaxel 5Chemoradiotherapy 5Tissue Banks 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × DNA × Head & Neck × Clear all
NCT04053114 2025-08-29

MOLTHYSO

Institut Bergonié

Withdrawn
GynecologicHead & Neck

Teratoma, Ovarian, Ovarian Neoplasms, Struma Ovarii, Thyroid Neoplasms

NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡